Similar Search Results

Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany : a comment

Gandjour, Afschin - In: The European journal of health economics 24 (2023) 7, pp. 1243-1244

Persistent link: https://www.econbiz.de/10014328184

Does health technology assessment compromise access to pharmaceuticals?

Büssgen, Melanie; Stargardt, Tom - In: The European journal of health economics 24 (2023) 7, pp. 1245-1248

Persistent link: https://www.econbiz.de/10014328187

The impact of reference pricing on switching behaviour and healthcare utilisation : the case of statins in Germany

Stargardt, Tom - In: The European journal of health economics : HEPAC ; … 11 (2010) 3, pp. 267-277

Persistent link: https://www.econbiz.de/10003978858

Modelling pharmaceutical price changes in Germany : a function of competition and regulation

Stargardt, Tom - In: Applied economics 43 (2011) 28/30, pp. 4515-4526

Persistent link: https://www.econbiz.de/10009388102

Reimbursement of pharmaceuticals : reference pricing versus health technology assessment

Drummond, Michael F.; Jönsson, Bengt; Rutten, F. F. H.; … - In: The European journal of health economics : HEPAC ; … 12 (2011) 3, pp. 263-271

Persistent link: https://www.econbiz.de/10009124305

The impact of physician-level drug budgets on prescribing behavior

Blankart, Katharina; Koch, Taika; Kostev, Karel; … - In: The European journal of health economics : HEPAC ; … 19 (2018) 2, pp. 213-222

Persistent link: https://www.econbiz.de/10011946212

Preferred supplier contracts in post-patent prescription drug markets

Blankart, Rudolf; Stargardt, Tom - In: Health care management science 20 (2017) 3, pp. 419-432

Persistent link: https://www.econbiz.de/10011741304

The diffusion of generics after patent expiry in Germany

Blankart, Katharina; Stargardt, Tom - In: The European journal of health economics : HEPAC ; … 17 (2016) 8, pp. 1027-1040

Persistent link: https://www.econbiz.de/10011660160

Harmonizing regulatory market approval of products with high safety requirements : evidence from the European pharmaceutical market

Grünwald, Fabian; Stargardt, Tom - In: Health economics 33 (2024) 7, pp. 1546-1564

Persistent link: https://www.econbiz.de/10014566060

The European COvid Survey (ECOS) : technical report

Sabat, Iryna; Neumann-Böhme, Sebastian; Stargardt, Tom; … - 2024

European COvid Survey (ECOS), a longitudinal study spanning eight European countries, was initiated early in the COVID-19 pandemic. Its purpose was to comprehend public perceptions, trust, knowledge, and behaviors related to COVID-19, including vaccination. The study aimed to enable timely...

Persistent link: https://www.econbiz.de/10014481219